Myrna Luna‐Gutiérrez

Molecular Targeting Radiotherapy with Cyclo-RGDfK(C) Peptides Conjugated to ¹⁷⁷Lu-Labeled Gold Nanoparticles in Tumor-Bearing Mice

Andrea Vilchis-Juárez, Guillermina Ferro‐Flores, Clara Santos‐Cuevas et al. · Journal of Biomedical Nanotechnology · 2013 · 104 citations

Medicine, Oncology, Radiation Oncology +17

Multifunctional targeted therapy system based on ^99mTc/¹⁷⁷Lu‐labeled gold nanoparticles‐Tat(49–57)‐Lys³‐bombesin internalized in nuclei of prostate cancer cells

Nallely Jiménez‐Mancilla, Guillermina Ferro‐Flores, Clara Santos‐Cuevas et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2013 · 87 citations

Pharmacy, Oncology, Pharmaceutics +17

Clinical translation of a PSMA inhibitor for 99m Tc-based SPECT

Guillermina Ferro‐Flores, Myrna Luna‐Gutiérrez, Blanca Ocampo‐García et al. · Nuclear Medicine and Biology · 2017 · 79 citations

Medicine, Nuclear Medicine, Pharmacology +16

Design, preparation, in vitro and in vivo evaluation of 99mTc-N2S2-Tat(49–57)-bombesin: A target-specific hybrid radiopharmaceutical

Clara Santos‐Cuevas, Guillermina Ferro‐Flores, Consuelo Arteaga de Murphy et al. · International Journal of Pharmaceutics · 2009 · 56 citations

Medicine, Nuclear Medicine, Pharmacokinetics +14

Fluorescent, Plasmonic, and Radiotherapeutic Properties of the ¹⁷⁷ Lu–Dendrimer-AuNP–Folate–Bombesin Nanoprobe Located Inside Cancer Cells

Héctor Mendoza-Nava, Guillermina Ferro‐Flores, Flor de Marı́a Ramı́rez et al. · Molecular Imaging · 2017 · 48 citations · Full text

Natural Sciences, Biophysics, Oncology +17